top of page

India ranks second in global cancer mortality

Very high number of patients relapse and/or refractory to conventional therapies: Leukaemia and Lymphoma*

High response rate: CAR-T cells are highly effective compared to chemotherapy, biologics and bone marrow transplant
* Based on inputs from multiple centres in India
bottom of page